What you should know:
1. Dr. Maple is a gastroenterologist at Oklahoma City-based University of Oklahoma College of Medicine. He used the truFreeze device to treat a patient with persistent nodular Barrett’s esophagus and to treat a cancer patient who had undergone chemotherapy but had, “a small amount of cancer remaining amenable to spray cryotherapy.”
2. Both patients were treated as outpatient and reported only minimal discomfort during and after the procedure.
3. Dr. Maple said, “Spray cryotherapy is associated with minimal pain, faster recovery and less harm to healthy tissue.”
4. CSA Medical’s truFreeze system is the only FDA-cleared option to treat patients with esophageal diseases.
More articles on gastroenterology:
AGA recognizes 10 GIs, researchers for achievements & contributions to the field
ASCs are ‘anxious to show their value’: Leapfrog CEO explains decision to lift survey cap
State fee schedule takes precedence over CMS list, New Jersey court rules — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
